Clinical Trials Detalhe
A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure
General Information
Gender
ALL
Age
from 18 Years to 99 Years
Phase
N/A
Study Type
OBSERVATIONAL
Location
Ponta Delgada, Portugal
Porto, Portugal
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT01241396Summary
The primary objective of this observational study is to document and describe current treatment regimens and disease progression of patients with Multiple Myeloma (MMY). The aim of this registry is to provide accurate, descriptive information on the way Multiple Myeloma is treated in routine clinical practice. The registry will collect information related to the treatment received for Multiple Myeloma. About 3000 patients will take part in the study in about 28 countries. The registry will only collect information that is already in medical files regarding treatment. Patients will not be required to actively do anything in addition to what would be done without participating in this registry, nor will there be any procedures or interventions that are not already part of the current treatment.
Conditions
Multiple Myeloma
Eligibility
Inclusion Criteria: \- Requires commencement of a new line of treatment for MMY at any stage, regardless of type of therapy selected. Exclusion Criteria: * Patients currently participating in another investigational study or clinical trial.